Browsing items tagged “Jim Lang | EVERSANA”

EVERSANA™ and Havas Health & You announce exclusive strategic partnership, optimizing global data & analytics platform, expansive network reach and commercialization expertise for life sciences category

CHICAGO – July 30, 2020 – EVERSANA™, the leading provider of commercial services to the life science industry, and Havas Health & You (HH&Y), the world’s largest global health and wellness network, today announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and […]

Vineti and EVERSANA™ form strategic alliance to advance patient-centered services and supply chain automation for regenerative medicine

Integrated Commercial Services and Personalized Therapy Management systems to seamlessly track product and patient journey SAN FRANCISCO, Calif. and CHICAGO, Illinois – July 29, 2020 – Vineti, the California-based company that offers a digital platform to enable broad access to advanced therapeutics, and EVERSANA™, a provider of global integrated commercial services to the life science […]

EVERSANA™ adds powerful predictive analytics platform with HVH Precision Analytics acquisition

Strengthens integrated commercial services with RWD and AI/ML Platform CHICAGO – July 15, 2020 – EVERSANA™, the leading provider of commercial services to the life science industry, today announced the acquisition of HVH Precision Analytics and its predictive analytics platform. Previously owned by Havas Health & You and Perspecta, and leveraging analytic expertise originally honed […]

EVERSANA™ appoints Kelly Baker to Chief Financial Officer

Seasoned financial executive to shepherd global growth and scale of commercial service platform CHICAGO – May 4, 2020 – EVERSANA™, the leading independent provider of global commercial services to the life sciences industry, today announced the appointment of Kelly Baker to Chief Financial Officer (CFO). Baker will direct the company’s financial excellence and lead the […]

EVERSANA™ launches data & analytics business to drive next-generation integrated commercial services

Company appoints healthcare data & analytics innovator Brigham Hyde, Ph.D. to lead platform launch CHICAGO – April 23, 2020 – EVERSANA™, the leading independent provider of global commercial services to the life sciences industry, today announced the appointment of Brigham Hyde, Ph.D. to President, Data & Analytics (D&A). Hyde will lead the company’s expansion into […]

EVERSANA™ unveils EVERSANA CONSULTING, portfolio of consulting services to solve challenges across the life sciences sector

CHICAGO – February 6, 2020  – Fueled by the growing demand for seasoned consulting expertise, EVERSANA™, the leading independent provider of commercial services to the life sciences industry, today unveiled EVERSANA CONSULTING, the new name of its global consulting services focused on the pharmaceutical and biotechnology industries. EVERSANA CONSULTING is built to address challenges across […]

Evoke Pharma Enters Commercialization Agreement with EVERSANA for Gimoti™

EVERSANA to commercialize and distribute Gimoti in the U.S. EVERSANA to provide $5 million revolving credit facility upon FDA approval SOLANA BEACH, CA, and CHICAGO, IL. January 23, 2020 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, an independent provider of global commercial services […]

EVERSANA™ launches EVERSANA ENGAGE, a full-solution marketing agency to reach patients, providers and payers across the care continuum

CHICAGO – January 7, 2020 – EVERSANA™, the leading independent provider of commercial services to the life sciences industry, today unveiled EVERSANA ENGAGE, the full-solution healthcare marketing agency uniquely designed to help pharmaceutical and biotechnology companies cohesively reach patients, providers and payers to enhance the patient experience and improve outcomes. EVERSANA ENGAGE combines EVERSANA’s market […]

EVERSANA™ announces an agreement to acquire Cornerstone Research Group; adds global HEOR capabilities to integrated commercial services platform

CHICAGO  – October 30, 2019  – EVERSANA™, the leading independent provider of commercial services to the life sciences industry, today announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Headquartered in Burlington, Ontario with an additional location in Sydney, Nova Scotia, Cornerstone Research Group is the leader in Health Economics and Outcomes Research (HEOR) […]

EVERSANA™ named a Great Place to Work by global workplace authority

CHICAGO – October 28, 2019 – EVERSANA™, the leading independent provider of commercial services to the life sciences industry, has been certified as a Great Place to Work® by the global authority in workplace culture. EVERSANA ranked in the top 15 percent of more than 6,000 organizations worldwide who have submitted for the coveted certification. […]